top of page

Navigate the demanding regulatory landscape with...

QMB's new SaaS platform for FDA regulation navigation

AI-driven, prescriptive planning for regulatory submissions, minimizes risk and maintains compliance within your organization...

Currently in development, our new SaaS product solution is an industry-first AI platform that guides MedTech and BioTech companies through the regulatory environment to accelerate their new product development while simultaneously driving internal quality compliance.
Users will be able to customize parameters for product-specific submissions, and with our true interactive interface will be guided through all the relevant output to execute a successful regulatory and compliance strategy.
We are currently engaging medtech industry partners (who focus on infusion pump systems and drug delivery) for beta testing QualiVerse in 2024. Please contact us for more information and let us know if you would like to be a part of our pilot program.
Qualiverse SaaS screenshot
Qualiverse a new SaaS regulatory platform
Qualiverse a new FDA regulatory navigations platform
bottom of page